Daniel Bach
Director/Board Member at Touchstone Innovations Investment Management Ltd.
Network origin in Daniel Bach first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
University of Barcelona
50
| College/University | Other Consumer Services | 50 |
IP Group Plc /Venture Capital/
 IP Group Plc /Venture Capital/ Investment ManagersFinance IP Group Plc /Venture Capital/ (IP Group) is a venture capital subsidiary of IP Group Plc founded in 2001. The firm is headquartered in London, United Kingdom.
22
| Operating Division | Investment Managers | 22 |
NanoDimension Management Ltd.
 NanoDimension Management Ltd. Investment ManagersFinance NanoDimension Management Ltd is a venture capital firm founded in 2002 by Aymeric Sallin. The firm is headquartered in George Town.
17
| Private Company | Investment Managers | 17 |
Index Ventures SA
 Index Ventures SA Investment ManagersFinance Index Ventures SA (Index Ventures) is a venture capital firm founded in 1996 by Neil Alexander Rimer, Gluseppe Zocco and Gerald Rimer. The firm is headquartered in Geneva, Switzerland.
12
| Private Company | Investment Managers | 12 |
Crescendo Biologics Ltd.
 Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom.
10
| Holding Company | Miscellaneous Commercial Services | 10 |
Touchstone Innovations Investment Management Ltd.
 Touchstone Innovations Investment Management Ltd. Investment ManagersFinance Touchstone Innovations Investment Management Ltd. is a Venture Capital firm, a subsidiary of Touchstone Innovations Ltd. founded in 1986. Touchstone Innovations Investment Management Ltd. is headquartered in London.
8
| Subsidiary | Investment Managers | 8 |
Vandria SA
 Vandria SA Pharmaceuticals: MajorHealth Technology Vandria SA is a Swiss-based company that specializes in mitochondrial therapeutics. The company is based in Lausanne, Switzerland. The company is developing mitophagy inducers that rejuvenate cells to treat age-related and chronic diseases. Its lead program, VNA-318, is a brain-penetrant, patent-protected, mitophagy inducer that has shown to improve memory and learning and to have strong disease-modifying effects in models of neurodegenerative diseases such as Alzheimer's and Parkinson's disease. Vandria is also developing mitophagy-inducing small molecules to address muscle, lung, and liver diseases, as well as a separate program that targets ferroptosis. The company was founded by Patrick Aebischer, Chris Rinsch, and Johan Auwerx in 2021 and has raised $20.60m in venture finance. Klaus Dugi has been the CEO of the company since 2021.
4
| Holding Company | Pharmaceuticals: Major | 4 |
CytoKi Pharma ApS
 CytoKi Pharma ApS Miscellaneous Commercial ServicesCommercial Services CytoKi Pharma ApS engages in the research and experimental development within biotechnology. It develops therapeutics for serious tissue and organ injuries. The company was founded by Rasmus Jørgensen on June 12, 2019 and is headquartered in Vaerlose, Denmark.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Aravis AG
 Aravis AG Investment ManagersFinance Aravis AG (Aravis) is an independent venture capital firm, founded in 2001 by Jean-Philippe Tripet and headquartered in Muttenz, Switzerland.
2
| Private Company | Investment Managers | 2 |
Escuela de Organización Industrial
1
| College/University | Other Consumer Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Daniel Bach via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| CERES POWER HOLDINGS PLC | Electronic Production Equipment | Director/Board Member Director/Board Member | |
| FUSION IP PLC | Miscellaneous Commercial Services | Founder Director/Board Member | |
| TOUCHSTONE INNOVATIONS PLC | Investment Managers | Corporate Secretary Director/Board Member Corporate Officer/Principal Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Chief Investment Officer Corporate Officer/Principal | |
| Stanford University | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
| University of Oxford | College/University | Undergraduate Degree Undergraduate Degree | |
| Imperial College London | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| École Polytechnique Fédérale de Lausanne | College/University | President Graduate Degree Doctorate Degree | |
| IP GROUP PLC | Miscellaneous Commercial Services | Chairman General Counsel Director/Board Member Director of Finance/CFO Director/Board Member Chief Executive Officer Corporate Officer/Principal Director/Board Member Director/Board Member | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Graduate Degree | |
IP2IPO Innovations Ltd.
 IP2IPO Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services IP2IPO Innovations Ltd. provides business development and technology transfer services. The firm also provides strategic industry University partnerships, patenting, licensing, spin-out incubation and equity management services. The company was founded in 1986 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| University of Navarra | College/University | Graduate Degree Masters Business Admin Graduate Degree | |
| University of Geneva | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| Swiss Federal Institute of Technology | College/University | President Graduate Degree Director/Board Member | |
| London Business School | College/University | Graduate Degree Masters Business Admin | |
| Escuela Superior de Administración y Dirección de Empresas | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| Ramon Llull University | College/University | Director/Board Member Graduate Degree | |
| CAIXABANK, S.A. | Regional Banks | Corporate Officer/Principal Director/Board Member General Counsel | |
Caixa Capital Risc SGEIC SA
 Caixa Capital Risc SGEIC SA Investment ManagersFinance Caixa Capital Risc SGEIC SA (Caixa Capital Risc) is a venture capital subsidiary of Criteria Caixa SA founded in 2002. The firm is headquartered in Barcelona, Spain with additional offices in Madrid. | Investment Managers | Private Equity Investor Private Equity Analyst Private Equity Investor | |
Magnomatics Ltd.
 Magnomatics Ltd. Industrial MachineryProducer Manufacturing Magnomatics Ltd. design and develops magnetic transmission systems, high-torque electrical machines and electromechanical actuators. Its products include pseudo direct drive, a high torque low speed motor and generator for actuation, fan motors, marine propulsion, and wind power applications and MAGSPLIT, a power-split continuously variable transmission solution for blended hybrid power trains and ancillary drives. The company serves oil and gas, automotive, aerospace, marine-propulsion, renewable energy, and rail traction and hybridization market sectors. The company was founded by Kais Atallah and Chris Kirby in 2006 and is headquartered in Sheffield, the United Kingdom. | Industrial Machinery | Director/Board Member Director/Board Member | |
Fusion IP Cardiff Ltd.
 Fusion IP Cardiff Ltd. Miscellaneous Commercial ServicesCommercial Services Part of IP Group Plc, Fusion IP Cardiff Ltd. engages in the commercialization of intellectual property. The company is based in London, UK. The British company was founded by Neil Warren. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Palau Pharma SA
 Palau Pharma SA BiotechnologyHealth Technology Palau Pharma SA is a holding company engaged in the discovery and development of biophamaceuticals for the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, neuropathic pain, and chronic obstructive pulmonary disease. The company was founded on March 13, 1991 and is headquartered in Palau Solita i Plegamans, Spain. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Fira Internacional de Barcelona
 Fira Internacional de Barcelona Miscellaneous Commercial ServicesCommercial Services Fira Internacional de Barcelona organizes trade shows and fairs, as well as corporate and socio-cultural events. It offers catering, logistics, transportation, accommodations, registration services for participants and guests. The company was founded in 1932, and is headquartered in Barcelona, Spain. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| Index Ventures (UK) LLP | Investment Managers | Private Equity Investor Private Equity Investor | |
Amazentis SA
 Amazentis SA Miscellaneous Commercial ServicesCommercial Services Amazentis SA is a Swiss innovative life science company that focuses on developing products targeting mitochondrial health for advanced nutrition. The company was founded in 2007 by Pierre Landolt, Patrick Aebischer, and Chris Rinsch, and it is currently based in Lausanne, Switzerland. The company has published its research on Mitopure™ Urolithin A in top peer-reviewed scientific journals, including Nature Medicine, Nature Metabolism, JAMA Network Open, and European Journal of Clinical Nutrition. Amazentis has a strategic partnership with Nestlé Health Science to expand the health applications of Mitopure™. Brian Ray has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Founder Director/Board Member Founder | |
Akamis Bio Ltd.
 Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member Director of Finance/CFO | |
ADman Interactive SL
 ADman Interactive SL Information Technology ServicesTechnology Services ADman Interactive SL provides video streaming platform. It offers video distribution for instream, out stream and native video. Its products include Intext, In-Banner, I-Spot, and native video. The company was founded by Josep Maria Tribó Capdevila, Marcos David Luengo Sánchez and Victor Sala Gracia in 2010 and is headquartered in Barcelona, Spain. | Information Technology Services | Chief Executive Officer Founder | |
Ability Pharmaceuticals SL
 Ability Pharmaceuticals SL BiotechnologyHealth Technology Ability Pharmaceuticals SL operates as a clinical stage drug discovery and development biopharmaceutical firm. It develops human therapeutics to treat cancer and other indications with unmet medical needs. The company was founded by Carles Domènech Garcia Jordi Espadaler Mazo in November 2009 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member Director/Board Member | |
MISSION Therapeutics Ltd.
 MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| Stanford University School of Medicine | College/University | Graduate Degree Doctorate Degree | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Graduate Degree | |
Inotrem SA
 Inotrem SA BiotechnologyHealth Technology Inotrem SA specializes in the development of therapeutic approaches based on its proprietary TREM-1 platform. The firm focuses on the control of immune reactions in acute inflammatory diseases. The company was founded by Jean-Jacques Garaud, Marc Derive and Sebastien Gibot in 2013 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member | |
Minoryx Therapeutics SL
 Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member Director/Board Member | |
Aelix Therapeutics SL
 Aelix Therapeutics SL BiotechnologyHealth Technology Aelix Therapeutics SL researches and develops therapies for HIV. It develops therapeutic vaccines and immunotherapies to treat HIV infection. The firm is a spin-off of HIVACAT, the Catalan project for the development of effective vaccines against HIV. The company was founded by Christian Brander, Bonaventura Clotet, Josep Maria Gatell and Jordi Naval is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member Director/Board Member | |
Lanai Partners SL
 Lanai Partners SL Investment ManagersFinance Lanai Partners SL (Lanai Partners) is a venture capital firm founded in 2016 by Jeroen Merchiers, Rubén Ferreiro, Guillermo Llibre and Mar Alarcón The firm is headquartered in Barcelona, Spain. | Investment Managers | Private Equity Investor Private Equity Investor | |
AptaTargets SL
 AptaTargets SL Pharmaceuticals: MajorHealth Technology AptaTargets SL is a biopharmaceutical company based in Madrid, Spain that focuses on developing therapeutic applications based on aptamer technology. The Spanish company is currently developing aptoll, an immune modulator that blocks the activation of tlr4 in a stroke, representing a novel approach to treat ischemic stroke in the acute phase. It could also be administered in patients up to 48 hours after the stroke. AptaTargets targets indications where inflammation causes significant damage through clinical studies and successful preclinical development. The company was founded in 2014 by David Segarra and María Eugenia Zarabozo, with David Segarra serving as the CEO since then. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| HOOKIPA PHARMA INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
SR One Capital Management LP
 SR One Capital Management LP Investment ManagersFinance SR One Capital Management LP (SR One) is a venture capital firm founded in 2020. The firm is headquartered in Redwood, California. | Investment Managers | Director/Board Member Private Equity Investor | |
IPG USA (LP) Ltd.
 IPG USA (LP) Ltd. Financial ConglomeratesFinance Part of IP Group Plc, IPG USA (LP) Ltd. functions as an investment holding British company. The company is based in London, UK and was founded in 2018. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Arctos Medical AG
 Arctos Medical AG BiotechnologyHealth Technology Arctos Medical AG engages in the acquisition, development, holding, registration, management, disposal, and exploitation of intellectual property rights and similar assets in the medical sector. These include patents, trademarks, licenses, industrial property rights, and inventions. The company was founded on June 6, 2012 and is headquartered in Bern, Switzerland. | Biotechnology | Chairman Founder | |
| ASPY GLOBAL SERVICES, S.A. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| ESADE Business School | College/University | Graduate Degree Undergraduate Degree | |
Kiko Ventures Ltd.
 Kiko Ventures Ltd. Investment ManagersFinance Kiko Ventures Ltd (Kiko Ventures) is a venture capital firm founded in 2020 by Robert Trezona. The firm is headquartered in London, England. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor | |
IP2IPO Ltd.
 IP2IPO Ltd. Miscellaneous Commercial ServicesCommercial Services Part of IP Group Plc, IP2IPO Ltd. is a British company that provides management consultancy services. The company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| AB-BIOTICS, S.A. | Pharmaceuticals: Other | Director/Board Member Chief Tech/Sci/R&D Officer |
Statistics
International
| United Kingdom | 21 |
| Spain | 17 |
| United States | 7 |
| Switzerland | 7 |
| France | 3 |
Sectoral
| Health Technology | 16 |
| Consumer Services | 16 |
| Finance | 11 |
| Commercial Services | 8 |
| Electronic Technology | 2 |
Operational
| Director/Board Member | 453 |
| Corporate Officer/Principal | 144 |
| Private Equity Investor | 108 |
| Undergraduate Degree | 59 |
| Independent Dir/Board Member | 55 |
Most connected contacts
| Insiders | |
|---|---|
| Michelangelo Volpi | 57 |
| David Baynes | 39 |
| Caroline Brown | 37 |
| Josep María Echarri Torres | 37 |
| Patrick Aebischer | 34 |
| Douglas Flint | 28 |
| Maina Bhaman | 26 |
| Graziano Seghezzi | 26 |
| James Rothschild | 22 |
| Pedro Fontana García | 19 |
| Aedhmar Brid Hynes | 19 |
| Marietta Wu | 19 |
| Gilles Nobécourt | 19 |
| Sara Secall Ruiz | 18 |
| Eva-Lotta Allan | 17 |
- Stock Market
- Insiders
- Daniel Bach
- Company connections
